These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26495991)

  • 21. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines.
    Chen HW; Pan CH; Liau MY; Jou R; Tsai CJ; Wu HJ; Lin YL; Tao MH
    J Virol; 1999 Dec; 73(12):10137-45. PubMed ID: 10559329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxyl-terminal truncation of Japanese encephalitis virus envelope glycoprotein.
    Jan LR; Yang CS; Henchal LS; Sumiyoshi H; Summers PL; Dubois DR; Lai CJ
    Am J Trop Med Hyg; 1993 Mar; 48(3):412-23. PubMed ID: 8385887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.
    Fernandez E; Kose N; Edeling MA; Adhikari J; Sapparapu G; Lazarte SM; Nelson CA; Govero J; Gross ML; Fremont DH; Crowe JE; Diamond MS
    mBio; 2018 Feb; 9(1):. PubMed ID: 29487230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Japanese encephalitis virus structural and nonstructural proteins expressed in Escherichia coli induce protective immunity in mice.
    Tafuku S; Miyata T; Tadano M; Mitsumata R; Kawakami H; Harakuni T; Sewaki T; Arakawa T
    Microbes Infect; 2012 Feb; 14(2):169-76. PubMed ID: 22001496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
    Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Japanese encephalitis virus peptide present on Johnson grass mosaic virus-like particles induces virus-neutralizing antibodies and protects mice against lethal challenge.
    Saini M; Vrati S
    J Virol; 2003 Mar; 77(6):3487-94. PubMed ID: 12610124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates.
    Sundaram AK; Ewing D; Blevins M; Liang Z; Sink S; Lassan J; Raviprakash K; Defang G; Williams M; Porter KR; Sanders JW
    Vaccine; 2020 Apr; 38(17):3313-3320. PubMed ID: 32184032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineation of an epitope on domain I of Japanese encephalitis virus Envelope glycoprotein using monoclonal antibodies.
    Gangwar RS; Shil P; Cherian SS; Gore MM
    Virus Res; 2011 Jun; 158(1-2):179-87. PubMed ID: 21477626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV.
    Widjaja I; Wicht O; Luytjes W; Leenhouts K; Rottier PJM; van Kuppeveld FJM; Haijema BJ; de Haan CAM
    J Virol; 2016 Jul; 90(13):5965-5977. PubMed ID: 27099320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
    Ge FF; Qiu YF; Yang YW; Chen PY
    Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis.
    Appaiahgari MB; Saini M; Rauthan M; Jyoti ; Vrati S
    Microbes Infect; 2006 Jan; 8(1):92-104. PubMed ID: 16126425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a pilot-scale production process and characterization of a recombinant Japanese encephalitis virus envelope domain III protein expressed in Escherichia coli.
    Tripathi NK; Shrivastava A; Biswal KC; Rao PV
    Appl Microbiol Biotechnol; 2012 Sep; 95(5):1179-89. PubMed ID: 22562165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
    Wu CJ; Huang HW; Tao MH
    Vaccine; 2003 Sep; 21(25-26):3938-45. PubMed ID: 12922129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple linear epitopes (B-cell, CTL and Th) of JEV expressed in recombinant MVA as multiple epitope vaccine induces a protective immune response.
    Wang F; Feng X; Zheng Q; Hou H; Cao R; Zhou B; Liu Q; Liu X; Pang R; Zhao J; Deng W; Chen P
    Virol J; 2012 Sep; 9():204. PubMed ID: 22985466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice.
    Wu Y; Zhang F; Ma W; Song J; Huang Q; Zhang H
    Microbiol Immunol; 2004; 48(8):585-90. PubMed ID: 15322338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus.
    Saga R; Fujimoto A; Watanabe N; Matsuda M; Hasegawa M; Watashi K; Aizaki H; Nakamura N; Tajima S; Takasaki T; Konishi E; Kato T; Kohara M; Takeyama H; Wakita T; Suzuki R
    Sci Rep; 2016 Jun; 6():28688. PubMed ID: 27345289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Monoclonal Antibody Specific for Japanese Encephalitis Virus with High Neutralizing Capability for Inclusion as a Positive Control in Diagnostic Neutralization Tests.
    Calvert AE; Bennett SL; Dixon KL; Blair CD; Roehrig JT
    Am J Trop Med Hyg; 2019 Jul; 101(1):233-236. PubMed ID: 31115302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
    Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
    Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein.
    Chiou SS; Fan YC; Crill WD; Chang RY; Chang GJ
    J Gen Virol; 2012 Jun; 93(Pt 6):1185-1192. PubMed ID: 22337639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine.
    Kim DK; Kim HY; Kim JY; Ye MB; Park KB; Han E; Kim J; Ja Ban S; Hong SH; Park YK; Nam JH
    Microbiol Immunol; 2012 Jul; 56(7):463-71. PubMed ID: 22486472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.